You heard it here first folks, unless you read the same Nature Communications article as me, in which case you heard it there first. Either way: 3D printed organs are a reality! For mice right now, but scale-wise it’s not that far from humans. This first foray into functioning 3D printed replacements involves a number of unique situations though, so don’t go ruining your liver just yet. – Read More –
Alright y’all, let’s get real. Most of us are pretty comfortable with the idea that mesenchymal stem cells (MSCs) can become cartilage, bone, fat, and connective tissue cells (among other awesome properties). Thousands upon thousands of patients’ worth of studies have been published using bone marrow-derived MSCs for everything from avascular necrosis to peripheral artery disease, many of which constitute the most effective, ground-breaking treatments for their respective pathologies. But it’s still not enough, right? If you’re at all like me, you hope to see stem cell technology evolve to the point of keeping spare parts in jars, so we can live in a future where organ donors are an archaic thing of the past. That is just not happening when MSCs can only become a select few cell types. Brace yourselves though: scientists just found a way to change that.
In my previous blog, I talked about the different routes used to deliver stem cells focusing on systemic delivery. Regardless of the delivery route chosen, labeling and tracking stem cells in vivo (within the organism) helps in determining their survival rate, where they migrated to and how many cells were retained in the area of interest. This provides us with insights into the therapeutic benefits of regenerative treatments. In this blog, I will discuss the current techniques being used to label stem cells. – Read More –